TW325473B - Azoamine derivative having methylene or substituted methylene on the amino ring - Google Patents

Azoamine derivative having methylene or substituted methylene on the amino ring

Info

Publication number
TW325473B
TW325473B TW083104253A TW83104253A TW325473B TW 325473 B TW325473 B TW 325473B TW 083104253 A TW083104253 A TW 083104253A TW 83104253 A TW83104253 A TW 83104253A TW 325473 B TW325473 B TW 325473B
Authority
TW
Taiwan
Prior art keywords
methylene
substituted
azoamine
derivative
amino ring
Prior art date
Application number
TW083104253A
Other languages
English (en)
Chinese (zh)
Inventor
Takanobu Naito
Harujin Kobayashi
Hironobu Ogura
Motomi Nagai
Tokiko Nishida
Original Assignee
Kaken Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharma Co Ltd filed Critical Kaken Pharma Co Ltd
Application granted granted Critical
Publication of TW325473B publication Critical patent/TW325473B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerization Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW083104253A 1993-05-10 1994-05-11 Azoamine derivative having methylene or substituted methylene on the amino ring TW325473B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13293193 1993-05-10

Publications (1)

Publication Number Publication Date
TW325473B true TW325473B (en) 1998-01-21

Family

ID=15092851

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083104253A TW325473B (en) 1993-05-10 1994-05-11 Azoamine derivative having methylene or substituted methylene on the amino ring

Country Status (15)

Country Link
US (3) US5620994A (Direct)
EP (1) EP0698606B1 (Direct)
KR (1) KR100339166B1 (Direct)
CN (1) CN1046278C (Direct)
AT (1) ATE161257T1 (Direct)
AU (1) AU685116B2 (Direct)
CA (1) CA2162463C (Direct)
DE (1) DE69407409T2 (Direct)
DK (1) DK0698606T3 (Direct)
ES (1) ES2110749T3 (Direct)
GR (1) GR3025715T3 (Direct)
HU (1) HU225416B1 (Direct)
TW (1) TW325473B (Direct)
UA (1) UA41365C2 (Direct)
WO (1) WO1994026734A1 (Direct)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0698606T3 (da) * 1993-05-10 1998-08-24 Kaken Pharma Co Ltd Azolylaminderivat
CA2233617A1 (en) * 1995-09-28 1997-04-03 Kaken Pharmaceutical Co., Ltd. Process for the preparation of 4-methylenepiperidine
ATE434667T1 (de) 1999-07-28 2009-07-15 Kaken Pharma Co Ltd Verfahren zum nachweis pathogener mikroorganismen und antimikrobieller mittel, verfahren zum nachweis der arzneimittelwirkung antimikrobieller mittel und antimikrobielle mittel
US20100080869A1 (en) * 2004-05-25 2010-04-01 Watson James B Live Bacteria product
US20090162419A1 (en) * 2004-05-25 2009-06-25 Watson James B Live bacteria product
US20090162481A1 (en) * 2004-05-25 2009-06-25 Watson James B Live bacteria product
US7625927B2 (en) * 2006-02-27 2009-12-01 Alcon Research, Ltd. Method of treating glaucoma
ES2350806T3 (es) 2006-12-28 2011-01-27 Kaken Pharmaceutical Co., Ltd. Composición de gel para el tratamiento de micosis.
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
CN106045970B (zh) * 2010-08-31 2019-11-08 科研制药株式会社 1-三唑-2-丁醇衍生物的制造方法
CN110433291B (zh) 2013-10-03 2023-04-28 博世健康爱尔兰有限公司 稳定的艾菲康唑组合物
CA3052643A1 (en) 2013-11-22 2015-05-28 Bausch Health Ireland Limited Anti-infective methods, compositions, and devices
CN104292214B (zh) * 2014-09-24 2017-04-05 南京华威医药科技开发有限公司 艾氟康唑及其中间体的合成方法
CN104327047B (zh) * 2014-10-17 2016-04-06 苏州明锐医药科技有限公司 艾菲康唑的制备方法
US9617241B2 (en) 2014-11-23 2017-04-11 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of efinaconazole
US20180002310A1 (en) * 2015-01-20 2018-01-04 Perrigo Api Ltd. Crystalline forms of efinaconazole
ITUB20150417A1 (it) 2015-05-08 2016-11-08 Dipharma Francis Srl Procedimento per la preparazione di composti piperidinici
EP3294723A1 (en) 2015-05-12 2018-03-21 Lupin Limited Process for the preparation of efinaconazole
EP3112360A1 (en) * 2015-06-29 2017-01-04 Dipharma Francis S.r.l. Process for the preparation of efinaconazole
CN106565672A (zh) * 2015-10-08 2017-04-19 中美华世通生物医药科技(武汉)有限公司 制备艾氟康唑的方法
US20170129874A1 (en) * 2015-11-10 2017-05-11 Virupaksha Organics Limited Novel improved process for preparing a triazole antifungal agent
CN106810534A (zh) * 2015-11-30 2017-06-09 中美华世通生物医药科技(武汉)有限公司 艾氟康唑晶型及其制备方法
CN106928186A (zh) * 2015-12-29 2017-07-07 中美华世通生物医药科技(武汉)有限公司 化合物及其制备方法和用途
ITUB20159795A1 (it) * 2015-12-30 2017-06-30 Procos Spa Processo per la sintesi di efinaconazolo
ITUA20162545A1 (it) 2016-04-13 2017-10-13 Laboratorio Chimico Int S P A Procedimento per la preparazione di intermedi utili nella sintesi di farmaci
WO2018115319A2 (en) 2016-12-23 2018-06-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases
IT201700048270A1 (it) 2017-05-04 2018-11-04 Seegpharm Sa Procedimento per la preparazione di un derivato azolico.
IL270691B (en) * 2017-05-19 2022-07-01 Kaken Pharma Co Ltd Production and purification methods for efinconazole
SG11201911637QA (en) 2017-08-10 2020-01-30 Sumitomo Chemical Co Process for producing epoxy alcohol compound
EP3885341A4 (en) * 2018-12-29 2022-08-10 Viwit Pharmaceutical Co., Ltd. METHOD FOR THE PREPARATION OF EFINACONAZOLE
KR102181155B1 (ko) 2019-09-26 2020-11-20 대봉엘에스 주식회사 이온성 액체를 매개로 한 에피나코나졸의 신규 제조방법
JP2021054781A (ja) 2019-09-26 2021-04-08 デボン エルエス,リミテッド 共結晶形エフィナコナゾール、及びその製造方法
KR102301743B1 (ko) 2020-12-29 2021-09-13 대봉엘에스 주식회사 에피나코나졸 경구용 조성물
CN118994102A (zh) * 2024-08-27 2024-11-22 张小宇 艾氟康唑衍生物及其抗真菌活性

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187399B (en) * 1980-12-24 1985-12-28 Sumitomo Chemical Co Process for preparing imidazolyl-propanol derivatives
US4507484A (en) * 1982-07-24 1985-03-26 Pfizer Inc. Triazole antifungal agents
GB8412750D0 (en) * 1984-05-18 1984-06-27 Ici Plc Heterocyclic compounds
DK0698606T3 (da) * 1993-05-10 1998-08-24 Kaken Pharma Co Ltd Azolylaminderivat

Also Published As

Publication number Publication date
EP0698606A4 (Direct) 1996-04-10
ES2110749T3 (es) 1998-02-16
US5620994A (en) 1997-04-15
CA2162463C (en) 2006-01-03
HU225416B1 (en) 2006-11-28
GR3025715T3 (en) 1998-03-31
HUT75031A (en) 1997-03-28
EP0698606A1 (en) 1996-02-28
ATE161257T1 (de) 1998-01-15
US5962476A (en) 1999-10-05
CN1122598A (zh) 1996-05-15
UA41365C2 (uk) 2001-09-17
KR100339166B1 (ko) 2004-04-30
AU685116B2 (en) 1998-01-15
DE69407409D1 (de) 1998-01-29
AU6689694A (en) 1994-12-12
DK0698606T3 (da) 1998-08-24
CA2162463A1 (en) 1994-11-24
HU9503217D0 (en) 1996-01-29
WO1994026734A1 (fr) 1994-11-24
US5716969A (en) 1998-02-10
EP0698606B1 (en) 1997-12-17
DE69407409T2 (de) 1998-04-09
CN1046278C (zh) 1999-11-10

Similar Documents

Publication Publication Date Title
TW325473B (en) Azoamine derivative having methylene or substituted methylene on the amino ring
CY1846A (en) 1-Indolylalkyl-4-(substituted-pyridinyl) piperazines
EP0906907A4 (Direct)
DK0787726T3 (da) Ny forbindelse, fremgangsmåde til fremstilling deraf og antitumor-middel
TW256832B (Direct)
CY1113359T1 (el) Αντι-νεοπλασιακα παραγωγα του et-743
GR3036795T3 (en) Novel fused indan derivative and pharmaceutically acceptable salt thereof
CA2218641A1 (en) Diaminofluorescein derivative
EP1447400A4 (en) BICYCLIC COMPOUND
NO302070B1 (no) Pyridinkarboksimidamid-forbindelse og anvendelse av samme
AU579443B2 (en) New cationic surfactants based on quaternary ammonium compounds and use thereof in cleaning agents
NO307883B1 (no) Antibakterielle pyridonkarboksylsyrederivater
ATE138364T1 (de) Hemmungsstoff für aldosereduktase
ES8800122A1 (es) Un procedimiento para la preparacion de derivados de indeno y naftaleno.
NZ304438A (en) Substituted triazole derivatives and antifungal compositions
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
ES8707540A1 (es) Un procedimiento para preparar derivados de penem
BG101267A (en) Bacteriacidal composition
ES8403866A1 (es) Un metodo de producir un derivado de 4-ciano-2-azetidinona.
ES8704158A1 (es) Procedimiento para la obtencion de derivados de diclorociclopropilalquilhidroxialquil-azol
MY101309A (en) Benzoylureas, and their production and use
HUP9702411A2 (hu) Fenoxi-alkil-amin-származékok és a vegyületeket tartalmazó antiaritmiás hatású gyógyszerkészítmények
ES2067388A1 (es) Procedimiento para la produccion de derivados de piroglutamato de configuracion 2,4-cis
MY101831A (en) Fungicides.
TH19545A (th) อนุพันธ์เพปไทด์

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees